Optimal Adjuvant Therapy Selection for Chinese BRAF V600-Mutant Stage III Melanoma: A Multicenter Efficacy Comparison of Targeted Agents, Immunotherapy, and Combinatorial Strategies
中国BRAF V600突变型III期黑色素瘤最佳辅助治疗方案选择:靶向药物、免疫疗法和联合治疗策略的多中心疗效比较
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70738
Zhang, Rongcheng; Liang, Yao; Li, Jingjing; Chen, Qianqi; Ding, Ya; Wen, Xizhi; Zhao, Baiwei; Zheng, Wei; Wu, Junwan; Zhang, Qiong; Chen, Ziluan; Ding, Qiuyue; Chen, Linbin; Li, Renai; Li, Ke; Zhou, Qiming; Zhang, Xiaoshi; Li, Dandan